Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0757-2025

STERILE MAGILL FORCEP (MAGF9), Medline Item No. 66790 Recall

STERILE MAGILL FORCEP (MAGF9), Medline Item No. 66790

FDA recall Class II

Ongoing

FDA lists this Class II recall for STERILE MAGILL FORCEP (MAGF9), Medline Item No. 66790. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0757-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Nov 12, 2024
FDA report date
Jan 1, 2025
Quantity in commerce
21,440 total
Distribution
See key details
FDA cause
Process control

What is being recalled?

STERILE MAGILL FORCEP (MAGF9), Medline Item No. 66790

Affected model & UDI checker

Search the exact identifiers published for Z-0757-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedSTERILE MAGILL FORCEP (MAGF9), Medline Item No. 66790Check source notice00653160007671
Not specifiedSTERILE MAGILL FORCEP (MAGF9), Medline Item No. 66790Check source notice50653160007676
FDA code information

UDI: 00653160007671 (ea) 50653160007676 (case); Lot 2023012390

View the original FDA recall notice

Why was this product recalled?

Weak seals may result in a breach of sterility, which may not be detectable to the user. This can lead to increased risk of contamination and infection.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did MEDLINE INDUSTRIES, LP - Northfield take?

On November 25, 2024, the firm notified customers via letters titled IMMEDIATE ACTION REQUIRED. Customers were informed that specific items and lots of Pure Pouch Single-Sterile and Sterile Kits are being recalled due to weak seals. Affected product must be destroyed. The letter included instructions on actions to take to be issued a credit. Customers should immediately check their stock for affected product and quarantine all units. Affected lots should be destroyed. When the recalling firm has received your completed destruction form, your account will be issued a credit, if applicable. If you have any questions, please contact 866-359-1704.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology